Journals / Turkish Journal of Internal Medicine / 2022 / Supplement 1

Post-transplant Lymphoproliferative Disorder Following Kidney Transplantation,

Pages
158–159
Publication Date
2022-04-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

After deceased kidney transplantation, we presented a young male patient diagnosed with diffuse large B-cell lymphoma.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Posttransplant lymphoproliferative diseases are complications that develop after solid organ transplantation.
📊
Key Findings & Data:Primary EBV infection is one of the most important risk factors.
💡
Conclusion & Impact:After deceased kidney transplantation, we presented a young male patient diagnosed with diffuse large B-cell lymphoma.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Post-transplant · Lymphoproliferative Disorder · Kidney Transplantation

Abstract

Posttransplant lymphoproliferative diseases are complications that develop after solid organ transplantation. Primary EBV infection is one of the most important risk factors. After deceased kidney transplantation, we presented a young male patient diagnosed with diffuse large B-cell lymphoma.

🔖

Cite This Article

CANDAR, Ö., TURNA, T. Z. (2022). Post-transplant Lymphoproliferative Disorder Following Kidney Transplantation,. Turkish Journal of Internal Medicine, Supplement 1, 158–159. https://ajindex.com/articles/809006

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (3)

  1. Maksten EF, Vase MØ, Kampmann J, d’Amore F, Møller MB, Strandhave C, Bendix K, Bistrup C, Thiesson HC, Søndergaard E, Hamilton-Dutoit S, Jespersen B. Post-transplant lymphoproliferative disorder following kidney transplantation: a population-based cohort study. Transpl Int. 2016 Apr;29(4):483- 93. doi: 10.1111/tri.12744. Bakker NA, van Imhoff GW, Verschuuren EA, van Son WJ. Presentation and early detection of post-transplant lymphoproliferative disorder after solid organ transplantation. Transpl Int. 2007 Mar;20(3):207-18. doi: 10.1111/j.1432- 2277.2006.00416.x. Al-Mansour Z, Nelson BP, Evens AM. Post-transplant lymphoproliferative disease (PTLD): Risk factors, diagnosis, and current treatment strategies. Curr Hematol Malig Rep. 2013 Sep;8(3):173-83. doi: 10.1007/s11899-013-0162-5.
  2. Green M, Michaels MG. Epstein-Barr virus infection and posttransplant lymphoproliferative disorder. Am J Transplant. 2013 Feb;13 Suppl 3:41-54; quiz 54. doi: 10.1111/ajt.12004.
  3. Hutton B, Joseph L, Yazdi F, Tetzlaff J, Hersi M, Kokolo M, Fergusson N, Bennett A, Buenaventura C, Fergusson D, Tricco A, Strauss S, Moher D, Knoll G. Checking whether there is an increased risk of post-transplant lymphoproliferative disorder and other cancers with specific modern immunosuppression regimens in renal transplantation: protocol for a network meta- analysis of randomized and observational studies. Syst Rev. 2014 Feb 22;3:16. doi: 10.1186/2046-4053-3-16.